| 发明名称 |
N-PROCALCITONIN-MODULATING AGENTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES |
| 摘要 |
<p>The invention relates to the use of an isolated peptide, an antibody or a fusion protein that can bind to NPCT, and the compositions and pharmaceutical forms comprising same, in the development of a medicament for the treatment and/or prevention of diseases related to the increase in beta-amyloids and/or tau hyperphosphorylation and/or neurotoxicity induced by domoic acid.</p> |
| 申请公布号 |
WO2015104443(A1) |
申请公布日期 |
2015.07.16 |
| 申请号 |
WO2015ES70004 |
申请日期 |
2015.01.08 |
| 申请人 |
SERVICIO ANDALUZ DE SALUD;UNIVERSIDAD DE SEVILLA;FUNDACIÓN PARA LA INVESTIGACIÓN BIOMÉDICA DEL HOSPITAL UNIVERSITARIO 12 DE OCTUBRE;CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES NEURODEGENERATIVAS (CIBERNED) |
发明人 |
TAVARES VAZQUEZ, EVA;MIÑANO SÁNCHEZ, JAVIER;CARRO DÍAZ, EVA MARÍA |
| 分类号 |
A61K39/395;A61P25/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
